Halotestin belong to a group of male sex hormones known as androgens. Halotestin (fluoxymesterone) is used to take care of male hypogonadism (androgen deficiency) in men, and also to treat delayed puberty in boys. Halotestin is also used for treating certain types of breast cancers that retort androgen treatment in women who are between one and five years past menopause.
Halotestin quantity varies widely according to the person and situation being addressed and the sternness of the condition. For male incompetence, the amount ranges from 5 mg to 20 mg on a daily basis. Generally, Halotestin is not given for longer than four to six months for this situation. On the other hand, for breast cancer in females, the quantity ranges from 10 mg to 40 mg each day, taken in three or four separated dosages.
How Halotestin is Available?
Halotestin pills are available as green, round tabs having fluoxymesterone 5 mg, and the other non-medicinal constituents comprising lactose, myrtiline green R, cornstarch, calcium stearate, FD&C Yellow No. 5 (tartrazine) and sucrose. It does not contain yeast, and is also well-known among power lifters and strength jocks. It is primarily used when athletes are more concerned in forting strength rather than building muscles.
What are Side Effects of Halotestin?
The less common or rare side effects of Halotestin include diarrhea, increase in pubic hair growth, decrease or increase in sexual desire, reduced testicle size (males), sleeping troubles, dizziness, frequent or continuous headache, nausea, rapid weight gain, yellow skin or eyes, confusion, constipation, increased thirst, and stomach pain. The more common fallouts include irregular menstrual cycles, hoarseness or deepening of voice, increase in size of female genitals, increased in body hair growth, male pattern baldness, decreased breast size, acne or oily skin, enlargement of penis, breast soreness or enlargement, erection of penis lasting for up to 4 hours or painful penile erections and frequent urge to urinate. Contact your doctor as soon as possible if these side effects occur.
Endocrine and urogenital
Female: the most common side effects of androgen therapy are amenorrhea and other menstrual irregularities; inhibition of gonadotropin secretion; and virilization, including deepening of the voice and clitoral enlargement. The latter usually is not reversible after androgens are discontinued. When administered to a pregnant woman, androgens can cause virilization of external genitalia of the female fetus.
Male: Gynecomastia, and excessive frequency and duration of penile erections. Oligospermia may occur at high dosage.
Skin and appendages
Hirsutism, male pattern of baldness, seborrhea, and acne.
Fluid and electrolyte disturbances
Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates.
Nausea, cholestatic jaundice, alterations in liver function tests, rarely hepatocellular neoplasms and peliosis hepatis.
Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia.
Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Hypersensitivity, including skin manifestations and anaphylactoid reactions.
Drug Abuse And Dependence
Controlled Substance Class: Fluoxymesterone is a controlled substance under the Anabolic Steroids Control Act, and HALOTESTIN (fluoxymesterone) Tablets has been assigned to Schedule III.
What are dosages of Halotestin?
The dosage will vary depending upon the individual, the condition being treated, and its severity. The total daily oral dose may be administered singly or in divided (three or four) doses.
For complete replacement in the hypogonadal male, a daily dose of 5 to 20 mg will suffice in the majority of patients. It is usually preferable to begin treatment with full therapeutic doses which are later adjusted to individual requirements. Priapism is indicative of excessive dosage and is indication for temporary withdrawal of the drug.
Dosage should be carefully titrated utilizing a low dose, appropriate skeletal monitoring, and by limiting the duration of therapy to four to six months.
Inoperable carcinoma of the breast in the female
The recommended total daily dose for palliative therapy in advanced inoperable carcinoma of the breast is 10 to 40 mg. Because of its short action, fluoxymesterone should be administered to patients in divided, rather than single, daily doses to ensure more stable blood levels. In general, it appears necessary to continue therapy for at least one month for a satisfactory subjective response, and for two to three months for an objective response.
Halotestin should not be used by anyone sensitive or allergic to fluoxymesterone or nonmedicinal constituents; anyone with severe liver disease, kidney disease, or heart disease; men with breast or prostate cancer; pregnant women and breast-feeding women. Don’t change the way that you are using the medicine without consulting your doctor.